James Schurr, MD, PharmD (@schurr_james) 's Twitter Profile
James Schurr, MD, PharmD

@schurr_james

Fellow @PennCardiology || IM @PennIMResidents || Crit Care Rx @BrighamPharmacy || shock and hemodynamics aficionado || #rstats || opinions rare & my own

ID: 1486176116100501510

calendar_today26-01-2022 03:16:29

11 Tweet

106 Followers

196 Following

James Schurr, MD, PharmD (@schurr_james) 's Twitter Profile Photo

From our multicenter experience: 1. ECMO bridged patients are sicker than non-bridged IMACS 1 and have worse but acceptable 1yr survival (75% w/ HM3) (should ECMO be IMACS 0?) 2. HM3 recipients had improved survival @mikegenuardi Michael Givertz Akram Zaaqoq Katelyn Sylvester

James Schurr, MD, PharmD (@schurr_james) 's Twitter Profile Photo

RV Failure after LVAD remains a vexing problem. Our review of this condition and management is now published in Journal of Shock and Hemodynamics! digitalcommons.library.tmc.edu/josh/vol2/iss2… Joyce Wald Filio Billia Penn Cardiology

RV Failure after LVAD remains a vexing problem. Our review of this condition and management is now published in Journal of Shock and Hemodynamics!

digitalcommons.library.tmc.edu/josh/vol2/iss2…

<a href="/DRJoycewald/">Joyce Wald</a> <a href="/FilioBillia/">Filio Billia</a> 
<a href="/PennCardiology/">Penn Cardiology</a>
Marwan Jumean, MD (@jumeanmarwan) 's Twitter Profile Photo

Right heart failure remains a major challenge post LVAD. Joyce Wald James Schurr, MD, PharmD and team explores #RHF and strategies for early recognition and intervention in Journal of Shock and Hemodynamics digitalcommons.library.tmc.edu/josh/vol2/iss2… #Cardiology #LVAD #HeartFailure